1 May 2025

The Lung Cancer Policy Network has published a new report detailing the importance of establishing high-quality patient navigation for lung cancer – the leading cause of cancer-related deaths.

The report, Patient navigation for lung cancer: an essential component of care, draws insights from Network members and 14 expert interviewees, as well as on the personal experiences of two navigators. It explores how health system leaders and decision-makers should develop formal patient navigation programmes where they do not exist, and provides recommendations about how to optimise those that do. These recommendations can be tailored to other health systems and countries.

The role of a patient navigator is to guide people with a particular condition through the health system, helping address unmet needs, mitigate barriers to timely diagnosis and treatment, and promote holistic, person-centred care.

However, for lung cancer, the potential of patient navigation to transform outcomes and deliver equitable access to best-practice care is yet to be fully realised. Further research is needed so health systems can optimise patient navigation to reduce costs, create efficiency and ensure that people receive high-quality, multidisciplinary care.

Download the report

Share

Recent news

Blog

Lung cancer: the looming economic crisis governments can’t ignore

Lung cancer: the looming economic crisis governments can’t ignore

Lung cancer carries a heavy cost – not only for the people diagnosed,  but for health systems and economies alike.

Blog

Beyond lung cancer: how LDCT screening could reshape early detection

Beyond lung cancer: how LDCT screening could reshape early detection

Health systems are under growing strain. The challenge is no longer simply how to treat illness, but how to detect it earlier and manage it more efficiently.

News

Insights from the I-ELCAP 3rd Annual AGILEᴰˣᴿˣ meeting

Insights from the I-ELCAP 3rd Annual AGILEᴰˣᴿˣ meeting

In March, the Network attended the International Early Lung Cancer Action Program 3rd Annual AGILEᴰˣᴿˣ meeting in Gdańsk, Poland.

The Lung Cancer Policy Network
Cookie Settings

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.